UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

microRNA blood signature for localized radiation injury

Scientific reports, 2024-02, Vol.14 (1), p.2681-2681, Article 2681

2024

Volltextzugriff (PDF)

Characterization of a new potent and long-lasting single chain peptide agonist of RXFP1 in cells and in vivo translational models

Scientific reports, 2022-11, Vol.12 (1), p.20435-20435, Article 20435

2022

Volltextzugriff (PDF)

Translational engagement of lysophosphatidic acid receptor 1 in skin fibrosis: from dermal fibroblasts of patients with scleroderma to tight skin 1 mouse

British journal of pharmacology, 2020-09, Vol.177 (18), p.4296-4309

2020

Volltextzugriff (PDF)

Introduction of Non-natural Amino Acids Into T-Cell Epitopes to Mitigate Peptide-Specific T-Cell Responses

Frontiers in immunology, 2021-03, Vol.12, p.637963-637963

2021

Volltextzugriff (PDF)

Fatty acid acylated peptide therapeutics: discovery of omega-n oxidation of the lipid chain as a novel metabolic pathway in preclinical species

Journal of pharmaceutical and biomedical analysis, 2023-04, Vol.227, p.115256-115256, Article 115256

2023

Volltextzugriff (PDF)

Lysophosphatidic Acid Receptor 1 Antagonist SAR100842 for Patients With Diffuse Cutaneous Systemic Sclerosis: A Double-Blind, Randomized, Eight-Week Placebo-Controlled Study Followed by a Sixteen-Week Open-Label Extension Study

Arthritis & rheumatology (Hoboken, N.J.), 2018-10, Vol.70 (10), p.1634-1643

2018

Volltextzugriff (PDF)

Healthy Donors Exhibit a CD4 T Cell Repertoire Specific to the Immunogenic Human Hormone H2-Relaxin before Injection

The Journal of immunology (1950), 2019-06, Vol.202 (12), p.3507-3513

2019

Volltextzugriff (PDF)

R2R01: A long‐acting single‐chain peptide agonist of RXFP1 for renal and cardiovascular diseases

British journal of pharmacology, 2024-07, Vol.181 (13), p.1993-2011

2024

Volltextzugriff (PDF)

Lysophosphatidic Acid Receptor 1 Antagonist SAR100842 for Patients With Diffuse Cutaneous Systemic Sclerosis

Arthritis & rheumatology (Hoboken, N.J.), 2018-10, Vol.70 (10), p.1634-1643

2018

Volltextzugriff (PDF)

Limited fibrosis accompanies triple-negative breast cancer metastasis in multiple model systems and is not a preventive target

Oncotarget, 2018-05, Vol.9 (34), p.23462-23481

2018

Volltextzugriff (PDF)

Inositol-requiring enzyme 1 pathway and autophagy drive sequential response of endothelial cells to febrile range hyperthermia

Archives of cardiovascular diseases, 2024-06, Vol.117 (6-7), p.S167-S167

2024

Volltextzugriff (PDF)

PCSK9 Modulates the Secretion But Not the Cellular Uptake of Lipoprotein(a) Ex Vivo

JACC. Basic to translational science, 2016-10, Vol.1 (6), p.419-427

2016

Volltextzugriff (PDF)

Calmodulin antagonists inhibit endothelium‐dependent hyperpolarization in the canine coronary artery

British journal of pharmacology, 1992-10, Vol.107 (2), p.382-386

1992

Volltextzugriff (PDF)

PCSK9 Modulates the Secretion But Not the Cellular Uptake of Lipoprotein(a) Ex Vivo: An Effect Blunted by Alirocumab

JACC. Basic to translational science, 2016-10, Vol.1 (6), p.419-427

2016

Volltextzugriff (PDF)

Abstract 16068: Biased Relaxin-RXFP1 Agonist ML290 Attenuates the Development of Pulmonary Hypertension

Circulation (New York, N.Y.), 2019-11, Vol.140 (Suppl_1 Suppl 1), p.A16068-A16068

2019

Volltextzugriff (PDF)

Potentiation of Endothelium-Dependent Relaxations to Bradykinin by Angiotensin I Converting Enzyme Inhibitors in Canine Coronary Artery Involves Both Endothelium-Derived Relaxing and Hyperpolarizing Factors

Circulation research, 1992-07, Vol.71 (1), p.137-144

1992

Volltextzugriff (PDF)

Abstract 16555: ML290, an Allosteric Agonist of RXFP1, Attenuates Experimental Pulmonary Hypertension

Circulation (New York, N.Y.), 2018-11, Vol.138 (Suppl_1 Suppl 1), p.A16555-A16555

2018

Volltextzugriff (PDF)

Bradykinin‐induced contractions of canine saphenous veins: mediation by B 2 receptors and involvement of eicosanoids

British journal of pharmacology, 2009-02, Vol.120 (2), p.215-220

2009

Volltextzugriff (PDF)

Abstract 20479: Relaxin Inhibits TGFβ-induced Pulmonary Artery Smooth Muscle Cell Fibrogenic Differentiation Via Modulation Of SMAD-ERK Signaling

Circulation (New York, N.Y.), 2016-11, Vol.134 (Suppl_1 Suppl 1), p.A20479-A20479

2016

Volltextzugriff (PDF)

Bradykinin‐induced contractions of canine saphenous veins: mediation by B2 receptors and involvement of eicosanoids

British journal of pharmacology, 1997-01, Vol.120 (2), p.215-220

1997

Volltextzugriff (PDF)

Calmidazolium, a calmodulin inhibitor, inhibits endothelium‐dependent relaxations resistant to nitro‐l‐arginine in the canine coronary artery

British journal of pharmacology, 1992-10, Vol.107 (2), p.387-392

1992

Volltextzugriff (PDF)

Potentiation by Trandolaprilat of the Endothelium-Dependent Hyperpolarization Induced by Bradykinin

Journal of cardiovascular pharmacology, 1994-06, Vol.23 Suppl 4, p.S6-10

1994

Volltextzugriff (PDF)

Regulation of nitric oxide‐like activity by prostanoids in smooth muscle of the canine saphenous vein

British journal of pharmacology, 1996-01, Vol.117 (2), p.360-364

1996

Volltextzugriff (PDF)

Potentiation by Trandolaprilat of the Endothelium-Dependent Hyperpolarization Induced by Bradykinin

Journal of cardiovascular pharmacology, 1994, Vol.23 Suppl 4, p.S6-10

1994

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(26)

Sprache

Englisch
(26)

Erscheinungsjahr

n.n

Thema

Science & Technology
(15)
Life Sciences & Biomedicine
(13)
Animals
(10)
Pharmacology & Pharmacy
(9)
Dogs
(8)
Biological And Medical Sciences
(6)
Humans
(6)
Life Sciences
(6)
Male
(6)
Bradykinin - Pharmacology
(5)
Fundamental And Applied Biological Sciences. Psychology
(5)
Vertebrates: Cardiovascular System
(5)
Blood Vessels And Receptors
(4)
Bradykinin
(4)
Endothelium, Vascular - Physiology
(4)
Female
(4)
In Vitro Techniques
(4)
Muscle, Smooth, Vascular - Physiology
(4)
Rats
(4)
Relaxin
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

microRNA blood signature for localized radiation injury

Characterization of a new potent and long-lasting single chain peptide agonist of RXFP1 in cells and in vivo translational models

Translational engagement of lysophosphatidic acid receptor 1 in skin fibrosis: from dermal fibroblasts of patients with scleroderma to tight skin 1 mouse

Introduction of Non-natural Amino Acids Into T-Cell Epitopes to Mitigate Peptide-Specific T-Cell Responses

Fatty acid acylated peptide therapeutics: discovery of omega-n oxidation of the lipid chain as a novel metabolic pathway in preclinical species

Lysophosphatidic Acid Receptor 1 Antagonist SAR100842 for Patients With Diffuse Cutaneous Systemic Sclerosis: A Double-Blind, Randomized, Eight-Week Placebo-Controlled Study Followed by a Sixteen-Week Open-Label Extension Study

Healthy Donors Exhibit a CD4 T Cell Repertoire Specific to the Immunogenic Human Hormone H2-Relaxin before Injection

R2R01: A long‐acting single‐chain peptide agonist of RXFP1 for renal and cardiovascular diseases

Identification of Potent and Long-Acting Single-Chain Peptide Mimetics of Human Relaxin‑2 for Cardiovascular Diseases

Lysophosphatidic Acid Receptor 1 Antagonist SAR100842 for Patients With Diffuse Cutaneous Systemic Sclerosis

Limited fibrosis accompanies triple-negative breast cancer metastasis in multiple model systems and is not a preventive target

Inositol-requiring enzyme 1 pathway and autophagy drive sequential response of endothelial cells to febrile range hyperthermia

PCSK9 Modulates the Secretion But Not the Cellular Uptake of Lipoprotein(a) Ex Vivo

Calmodulin antagonists inhibit endothelium‐dependent hyperpolarization in the canine coronary artery

PCSK9 Modulates the Secretion But Not the Cellular Uptake of Lipoprotein(a) Ex Vivo: An Effect Blunted by Alirocumab

Abstract 16068: Biased Relaxin-RXFP1 Agonist ML290 Attenuates the Development of Pulmonary Hypertension

Potentiation of Endothelium-Dependent Relaxations to Bradykinin by Angiotensin I Converting Enzyme Inhibitors in Canine Coronary Artery Involves Both Endothelium-Derived Relaxing and Hyperpolarizing Factors

Abstract 16555: ML290, an Allosteric Agonist of RXFP1, Attenuates Experimental Pulmonary Hypertension

Bradykinin‐induced contractions of canine saphenous veins: mediation by B 2 receptors and involvement of eicosanoids

Abstract 20479: Relaxin Inhibits TGFβ-induced Pulmonary Artery Smooth Muscle Cell Fibrogenic Differentiation Via Modulation Of SMAD-ERK Signaling

Bradykinin‐induced contractions of canine saphenous veins: mediation by B2 receptors and involvement of eicosanoids

Calmidazolium, a calmodulin inhibitor, inhibits endothelium‐dependent relaxations resistant to nitro‐l‐arginine in the canine coronary artery

Potentiation by Trandolaprilat of the Endothelium-Dependent Hyperpolarization Induced by Bradykinin

Regulation of nitric oxide‐like activity by prostanoids in smooth muscle of the canine saphenous vein

Potentiation by Trandolaprilat of the Endothelium-Dependent Hyperpolarization Induced by Bradykinin

Suchergebnisse filtern